Components:
Method of action:
Medically reviewed by Oliinyk Elizabeth Ivanovna, PharmD. Last updated on 26.06.2023
Attention! Information on this page is intended only for medical professionals! Information is collected in open sources and may contain significant errors! Be careful and double-check all the information on this page!
Inside.
Take before meals, with a sufficient amount of water.
The duration of the course of treatment is at least 3 months.
Adults and children over 12 years of age: treatment of severe liver damage begins with a daily dose of 420 mg (4 tablets 3 times a day). In milder cases and as maintenance therapy-1-2 tablets 3 times a day.
Prophylactically take 2-3 pills a day.
- Hepatoprotective agent [Hepatoprotectors]
In a dry place, protected from light, at a temperature not exceeding 25 °C.
Keep out of reach of children.
Shelf life of the drug Karsil®2 года.Do not use after the expiration date indicated on the package.
| Jelly beans | 1 dragee |
| active substance: | |
| milk thistle spotted fruit extract dry (equivalent to silymarin) | 35 mg |
| excipients | |
| the core: lactose monohydrate-55.38 mg, wheat starch — 55.38, povidone (collidone 25) - 1.65 mg, MCC-67 mg, magnesium stearate-2.5 mg, talc-7 mg, dextrose monohydrate-20.6 mg, sorbitol-4.13 mg, sodium bicarbonate-1.36 mg | |
| shell: cellacephate — 0.84 mg, diethyl phthalate — 0.6 mg, sucrose — 162.19 mg, acacia gum — 1.562 mg, gelatin — 0.86 mg, talc — 26.718 mg, titanium dioxide — 4.82 mg, macrogol (PEG 6000) — 0.13 mg, Brown Opalux dye (sucrose, iron oxide red, iron oxide black, methyl and propyl parahydroxybenzoate, water cleaned up) - 2.25 mg, glycerol-0.03 mg |
Tablets, 35 mg. In blisters made of PVC film and aluminum foil of 10 pcs., in a pack of cardboard 8 or 18 bl.
Without a prescription.
A05BA03 Silymarin
- B94. 2 Long-term effects of viral hepatitis
- K70 Alcoholic liver disease
- K70. 0 Alcoholic fatty liver dystrophy [fatty liver]
- K71 Toxic liver damage
- K73. 9 Chronic hepatitis, unspecified
- K74 Fibrosis and cirrhosis of the liver
- K76. 0 Fatty liver degeneration, not classified elsewhere
- K76. 9 Liver disease, unspecified
- T50. 9 Other and unspecified medicinal products, medicines and biological substances
- T51 Toxic effects of alcohol
- T65. 9 Toxic effect of an unspecified substance
- Y57 Adverse reactions in the therapeutic use of other and unspecified drugs and medications
- Z57 Occupational exposure to risk factors
